Skip to main content

How is Kymriah administered?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on May 24, 2024.

Official answer

by drugclasses.com

Kymriah is administered as a suspension through a tube (intravenous catheter) into your vein. This single-dose infusion usually takes less than one hour.

Kymriah is only given to you at a certified healthcare facility. You can see a list of treatment centers here.

Once you receive Kymriah, you should plan to stay within 2 hours of the location where you received treatment for at least 4 weeks. Your healthcare providers will check on you frequently to monitor how well your treatment is working and for possible side effects.

Before you receive Kymriah, you may have chemotherapy for a few days to help prepare your body to receive the treatment.

What did the FDA approve Kymriah for?

  • Kymriah (tisagenlecleucel) is a chimeric antigen receptor T cell (CAR-T) therapy used in pediatric and young adult patients (up to age 25) with B-cell acute lymphoblastic leukemia (ALL) that has come back or did not respond to initial treatments (called relapsed or refractory).
  • It is also approved in adults to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a type of non-Hodgkin lymphoma, after having at least two other kinds of treatment.
  • In May 2022, the FDA approved Kymriah for adults with relapsed or refractory follicular lymphoma (FL).
  • ALL, DLBCL and FL are all types of blood cancers.

Related questions

How is Kymriah made?

Kymriah is made from your own white blood cells in a process called leukapheresis.

  • A tube (intravenous catheter) is placed in your vein to collect white blood cells from the blood. Leukapheresis takes 3 to 6 hours and may need to be repeated.
  • The blood cells are frozen and sent to the manufacturing site to make tisagenlecleucel (Kymriah).
  • It takes roughly 3 to 4 weeks to make Kymriah, but this time can vary. Once the medicine is made, it is shipped back to your healthcare provider.

This is not all the information you need to know about Kymriah (tisagenlecleucel) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Kymriah information here, and discuss this information and any questions you have with your doctor or other health care provider.

References

Read next

What type of drug is Kymriah (tisagenlecleucel)?

Kymriah (tisagenlecleucel) is a chimeric antigen receptor T cell (CAR-T) therapy. In CAR-T cell therapy, a patient's cells are genetically modified to include a new protein that directs that specific white blood cell (known as T-cell) to target and kill leukemia cells. Continue reading

What to avoid when taking Gleevec?

Talk to your doctor about warnings, side effects, use in pregnancy and possible drug interactions with Gleevec. Take your Gleevec exactly as prescribed by your doctor. Do not use Gleevec if you are pregnant or planning a pregnancy. Take each tablet with a meal and large glass of water to help prevent stomach irritation. Do not use grapefruit products while taking Gleevec. Use caution with driving as Gleevec may cause dizziness, drowsiness or blurred vision. Continue reading

How much does Tecartus cost?

Tecartus costs $373,000 as a one time CAR-T immunotherapy cancer treatment. Most people do not pay for this medicine themselves. It is a personalized medicine engineered from a patient’s own white blood cells. Costs may be covered by your insurance plan, patient assistance programs, or financial resources offered through the manufacturer. Continue reading

Related medical questions

Drug information

Related support groups